Imatinib mesylate-induced pseudoporphyria

J Am Acad Dermatol. 2010 Jul;63(1):e14-6. doi: 10.1016/j.jaad.2010.01.060.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antineoplastic Agents / adverse effects*
  • Benzamides
  • Diagnosis, Differential
  • Female
  • Humans
  • Imatinib Mesylate
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy
  • Middle Aged
  • Piperazines / adverse effects*
  • Porphyria Cutanea Tarda / chemically induced*
  • Porphyria Cutanea Tarda / diagnosis*
  • Pyrimidines / adverse effects*

Substances

  • Antineoplastic Agents
  • Benzamides
  • Piperazines
  • Pyrimidines
  • Imatinib Mesylate